China formally joins WHO led COVAX initiative on COVID-19 vaccine


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ China formally joins WHO led COVAX initiative on COVID-19 vaccine
The COVAX facility, led by the World Health Organization, aims to deliver at least 2 billion doses of vaccines by the end of 2021

China has formally joined COVAX, the global initiative for COVID-19 vaccine by signing an agreement with Gavi, the Vaccine Alliance on Thursday.

Chinese Foreign Ministry Spokesperson Hua Chunying announced this in a statement issued today. The statement did not give details on the level of support Beijing will provide to the initiative.

The COVAX facility, led by the World Health Organization (WHO), aims to deliver at least 2 billion doses of vaccines by the end of 2021.

The WHO had said it had been negotiating with China for its participation in the initiative, with Russia and the United States so far choosing not to join.

More than 150 countries have joined the WHO led initiative to develop, produce, and fairly distribute an effective COVID-19 vaccine. China is the biggest economy so far to join COVAX which aims to create a 15 billion dollars corpus for delivering at least 2 billion doses of vaccines by the end of 2021.

Ms Hua also said that China has ample COVID-19 vaccine production capacity and it will be provided to developing countries as a priority when vaccines are ready. The statement also said that China hopes more capable countries will also join and support COVAX.

A report issued by the WHO in September has given an idea of how the facility will distribute vaccine doses, when they become available. The WHO estimates that an allocation of doses equal to 20% of a country’s population should be enough to vaccinate people at the highest priority.

In the initial phases, when doses are expected to be in short supply, countries will receive doses in tranches until they have enough to vaccinate 3% of their populations.

Tags : #China #LatestPharmaNews9thOct #LatestCovidVaccineNews9thOct #WHO #HuaChunying #Russia #UnitedStates #VaccineAlliance

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026